Gemina Laboratories Management
Management criteria checks 1/4
Gemina Laboratories' CEO is Brian Firth, appointed in Sep 2022, has a tenure of 2.33 years. directly owns 0.067% of the company’s shares, worth €21.24K. The average tenure of the management team and the board of directors is 2.9 years and 3 years respectively.
Key information
Brian Firth
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.07% |
| Management average tenure | 2.9yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | -CA$4m |
| Apr 30 2024 | n/a | n/a | -CA$4m |
| Jan 31 2024 | n/a | n/a | -CA$5m |
| Oct 31 2023 | n/a | n/a | -CA$6m |
| Jul 31 2023 | n/a | n/a | -CA$6m |
| Apr 30 2023 | n/a | n/a | -CA$7m |
| Jan 31 2023 | CA$104k | CA$104k | -CA$6m |
Compensation vs Market: Insufficient data to establish whether Brian's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Insufficient data to compare Brian's compensation with company performance.
CEO
Brian Firth
2.3yrs
Tenure
CA$104,167
Compensation
Mr. Brian Firth is Chief Executive Officer of Gemina Laboratories Ltd. from September 1,2022 and also serves as its Director since January 12, 2023. He brings to Gemina an enviable career, focused on healt...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.3yrs | CA$104.17k | 0.067% € 21.2k | |
| CFO & Company Secretary | 3.8yrs | CA$57.14k | no data | |
| CTO & Director | 4.3yrs | CA$155.66k | 0.056% € 17.8k | |
| VP of Marketing & Member of Advisory Board | no data | no data | no data | |
| Head of Productization & Director of Gemina Laboratories (UK) Limited | 2.9yrs | no data | no data | |
| Head of Product Development | 2yrs | no data | no data |
2.9yrs
Average Tenure
Experienced Management: 8I7's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2yrs | CA$104.17k | 0.067% € 21.2k | |
| CTO & Director | 4yrs | CA$155.66k | 0.056% € 17.8k | |
| VP of Marketing & Member of Advisory Board | 5yrs | no data | no data | |
| Chair of Clinical Advisory Board | 2.1yrs | no data | no data | |
| Independent Chairman | 4yrs | CA$107.25k | 0.054% € 17.0k | |
| Independent Director | 3.8yrs | CA$10.00k | 0.098% € 31.0k | |
| Independent Director | 2yrs | CA$324.00 | no data | |
| Independent Director | 1.8yrs | no data | no data |
3.0yrs
Average Tenure
Experienced Board: 8I7's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/16 19:54 |
| End of Day Share Price | 2025/01/16 00:00 |
| Earnings | 2024/07/31 |
| Annual Earnings | 2024/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Gemina Laboratories Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|